Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension
7680006400030
CH-640
Pulver
Associated product:
INFANRIX hexa susp inj (n ser pré) 0.5 ml
1 / 3
google
Article details
- Package size
- 1 x 1
- Selling units
- unbekannt
- Measure
- Kombipackung(en)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
II
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
- | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | Wirkstoff (Principe actif) |
|
12C
|
- | Substance | Wirkstoff (Principe actif) |
|
I
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
0.12 MG | Substance | HBESI |
|
12C
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
12C
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
40.0 UI | Substance | Wirkstoff (Principe actif) |
|
12C
|
40.0 UI | Substance | Wirkstoff (Principe actif) |
|
I
|
8.0 UI | Substance | Wirkstoff (Principe actif) |
|
12C
|
8.0 UI | Substance | Wirkstoff (Principe actif) |
|
I
|
32.0 UI | Substance | Wirkstoff (Principe actif) |
|
12C
|
32.0 UI | Substance | Wirkstoff (Principe actif) |
|
I
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
0.5 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
12C
|
0.5 MG | Substance | HBESI |
|
12C
|
- | Substance | HNIDK |
|
I
|
0.2 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
12C
|
0.32 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
I
|
1.8 MG | Substance | HBESI |
|
12C
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
12C
|
1.8 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
I
|
- | Substance | RESI |
|
I
|
- | Substance | RESI |
|
I
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
|
I
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
|
I
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
Reimbursement information
Public price
CHF 72.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2001
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 640
- Drug name
- Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension
- Galenic form
- PULSIN
- ATC Code
- J07CA09
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 02/10/2000
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- INFANRIX hexa susp inj (n ser pré) 0.5 ml
- Description (DE)
- INFANRIX hexa Inj Susp (n Fertspr) 0.5 ml
- Market launch
- 02/10/2000
- Narcotic (BTM)
- No
Application methods
IMU